| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart Failure | 17 | 2017 | 123 | 4.900 |
Why?
|
| Depression | 20 | 2018 | 410 | 3.140 |
Why?
|
| Women's Health | 27 | 2022 | 137 | 3.030 |
Why?
|
| Intra-Abdominal Fat | 9 | 2016 | 26 | 2.440 |
Why?
|
| Asthma | 6 | 2015 | 103 | 2.230 |
Why?
|
| Patient Compliance | 11 | 2017 | 145 | 2.210 |
Why?
|
| Middle Aged | 96 | 2022 | 8556 | 1.940 |
Why?
|
| Obesity | 12 | 2022 | 292 | 1.920 |
Why?
|
| Menopause | 18 | 2018 | 78 | 1.870 |
Why?
|
| Self Care | 9 | 2016 | 83 | 1.790 |
Why?
|
| Medication Adherence | 6 | 2016 | 38 | 1.790 |
Why?
|
| Female | 107 | 2022 | 14543 | 1.760 |
Why?
|
| Behavior Therapy | 11 | 2023 | 82 | 1.710 |
Why?
|
| Humans | 128 | 2023 | 25900 | 1.550 |
Why?
|
| Social Support | 14 | 2018 | 187 | 1.470 |
Why?
|
| Patient Education as Topic | 8 | 2011 | 118 | 1.410 |
Why?
|
| Obesity, Abdominal | 4 | 2015 | 13 | 1.280 |
Why?
|
| Cardiovascular Diseases | 12 | 2016 | 277 | 1.240 |
Why?
|
| Exercise | 5 | 2018 | 415 | 1.230 |
Why?
|
| Adrenal Cortex Hormones | 3 | 2015 | 96 | 1.230 |
Why?
|
| Myocardial Infarction | 19 | 2009 | 106 | 1.170 |
Why?
|
| Risk Factors | 38 | 2022 | 2173 | 1.060 |
Why?
|
| Stress, Psychological | 10 | 2012 | 224 | 1.050 |
Why?
|
| Quality of Life | 6 | 2016 | 563 | 1.040 |
Why?
|
| Adiposity | 7 | 2017 | 32 | 1.040 |
Why?
|
| Guideline Adherence | 3 | 2017 | 52 | 1.020 |
Why?
|
| Depressive Disorder | 11 | 2018 | 168 | 0.960 |
Why?
|
| Male | 50 | 2022 | 14176 | 0.950 |
Why?
|
| Hospitalization | 8 | 2016 | 295 | 0.940 |
Why?
|
| Adult | 42 | 2022 | 7517 | 0.900 |
Why?
|
| Breast Neoplasms | 6 | 2013 | 381 | 0.900 |
Why?
|
| Body Mass Index | 12 | 2017 | 431 | 0.880 |
Why?
|
| Disease Management | 2 | 2017 | 91 | 0.870 |
Why?
|
| Life Style | 9 | 2018 | 180 | 0.870 |
Why?
|
| Poverty | 4 | 2016 | 91 | 0.860 |
Why?
|
| Prejudice | 4 | 2013 | 35 | 0.860 |
Why?
|
| Healthcare Disparities | 3 | 2015 | 82 | 0.850 |
Why?
|
| Spirituality | 4 | 2009 | 79 | 0.840 |
Why?
|
| Chicago | 14 | 2016 | 906 | 0.830 |
Why?
|
| Minority Groups | 7 | 2018 | 74 | 0.830 |
Why?
|
| Urban Population | 3 | 2015 | 146 | 0.800 |
Why?
|
| Health Knowledge, Attitudes, Practice | 5 | 2014 | 155 | 0.790 |
Why?
|
| Smoking Cessation | 1 | 2023 | 46 | 0.790 |
Why?
|
| Atherosclerosis | 4 | 2018 | 49 | 0.780 |
Why?
|
| Mexican Americans | 2 | 2013 | 26 | 0.780 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2023 | 44 | 0.780 |
Why?
|
| Weight Reduction Programs | 2 | 2022 | 20 | 0.780 |
Why?
|
| Community Health Workers | 2 | 2013 | 27 | 0.770 |
Why?
|
| Socioeconomic Factors | 15 | 2017 | 284 | 0.760 |
Why?
|
| Stress Disorders, Post-Traumatic | 2 | 2015 | 222 | 0.760 |
Why?
|
| Metabolic Syndrome | 3 | 2018 | 51 | 0.750 |
Why?
|
| Coronary Artery Disease | 8 | 2022 | 97 | 0.750 |
Why?
|
| Diabetes Mellitus, Type 2 | 3 | 2013 | 155 | 0.720 |
Why?
|
| United States | 29 | 2019 | 1935 | 0.720 |
Why?
|
| Health Behavior | 4 | 2013 | 155 | 0.690 |
Why?
|
| Chronic Disease | 6 | 2016 | 403 | 0.670 |
Why?
|
| Uterine Cervical Neoplasms | 2 | 2013 | 33 | 0.660 |
Why?
|
| Postmenopause | 11 | 2017 | 51 | 0.640 |
Why?
|
| Health Status | 6 | 2011 | 198 | 0.640 |
Why?
|
| Hostility | 6 | 2009 | 24 | 0.620 |
Why?
|
| Absorptiometry, Photon | 4 | 2015 | 79 | 0.620 |
Why?
|
| Physician-Patient Relations | 3 | 2017 | 40 | 0.620 |
Why?
|
| Exercise Therapy | 2 | 2018 | 82 | 0.620 |
Why?
|
| Body Fat Distribution | 3 | 2016 | 8 | 0.610 |
Why?
|
| Surveys and Questionnaires | 13 | 2016 | 1083 | 0.610 |
Why?
|
| Depressive Disorder, Major | 2 | 2015 | 91 | 0.600 |
Why?
|
| Personal Satisfaction | 2 | 2016 | 41 | 0.600 |
Why?
|
| Cross-Sectional Studies | 15 | 2016 | 847 | 0.600 |
Why?
|
| Diet Therapy | 1 | 2018 | 10 | 0.600 |
Why?
|
| Treatment Outcome | 14 | 2017 | 3339 | 0.590 |
Why?
|
| Counseling | 7 | 2013 | 41 | 0.590 |
Why?
|
| Cohort Studies | 16 | 2016 | 1815 | 0.560 |
Why?
|
| Follow-Up Studies | 20 | 2017 | 1708 | 0.560 |
Why?
|
| Aged | 25 | 2019 | 8658 | 0.550 |
Why?
|
| Coronary Disease | 10 | 2013 | 49 | 0.550 |
Why?
|
| Carotid Intima-Media Thickness | 2 | 2018 | 16 | 0.540 |
Why?
|
| Mass Screening | 3 | 2016 | 168 | 0.540 |
Why?
|
| Hydrocortisone | 2 | 2010 | 35 | 0.530 |
Why?
|
| Food Services | 1 | 2016 | 2 | 0.520 |
Why?
|
| Child Nutrition Sciences | 1 | 2016 | 3 | 0.520 |
Why?
|
| Diet Records | 1 | 2016 | 11 | 0.520 |
Why?
|
| Motor Activity | 2 | 2009 | 309 | 0.520 |
Why?
|
| Data Collection | 2 | 2016 | 87 | 0.520 |
Why?
|
| Abdominal Fat | 2 | 2015 | 5 | 0.510 |
Why?
|
| Assertiveness | 2 | 2015 | 6 | 0.510 |
Why?
|
| Schools | 1 | 2016 | 45 | 0.510 |
Why?
|
| Longitudinal Studies | 18 | 2019 | 1324 | 0.500 |
Why?
|
| Adolescent | 7 | 2016 | 2070 | 0.500 |
Why?
|
| Diet, Sodium-Restricted | 1 | 2016 | 10 | 0.500 |
Why?
|
| Psychotherapy | 1 | 2016 | 37 | 0.490 |
Why?
|
| Self Efficacy | 2 | 2014 | 53 | 0.490 |
Why?
|
| Comorbidity | 8 | 2016 | 457 | 0.480 |
Why?
|
| Lung Diseases | 1 | 2015 | 43 | 0.470 |
Why?
|
| Wounds and Injuries | 1 | 2015 | 44 | 0.470 |
Why?
|
| Child | 6 | 2016 | 1180 | 0.470 |
Why?
|
| Directive Counseling | 2 | 2016 | 10 | 0.470 |
Why?
|
| Heart Diseases | 1 | 2015 | 50 | 0.470 |
Why?
|
| Primary Health Care | 1 | 2016 | 80 | 0.460 |
Why?
|
| Anti-Asthmatic Agents | 1 | 2015 | 14 | 0.460 |
Why?
|
| Health Status Disparities | 2 | 2015 | 73 | 0.460 |
Why?
|
| Adipose Tissue | 5 | 2019 | 71 | 0.460 |
Why?
|
| Calcinosis | 5 | 2016 | 38 | 0.430 |
Why?
|
| Odds Ratio | 9 | 2016 | 254 | 0.430 |
Why?
|
| Social Perception | 1 | 2013 | 12 | 0.420 |
Why?
|
| Coronary Vessels | 6 | 2022 | 29 | 0.410 |
Why?
|
| Carotid Artery Diseases | 3 | 2009 | 12 | 0.410 |
Why?
|
| Vascular Calcification | 3 | 2022 | 9 | 0.410 |
Why?
|
| Telemedicine | 1 | 2015 | 87 | 0.410 |
Why?
|
| Logistic Models | 10 | 2014 | 368 | 0.410 |
Why?
|
| Blood Pressure | 3 | 2013 | 179 | 0.400 |
Why?
|
| Subcutaneous Fat | 2 | 2009 | 7 | 0.390 |
Why?
|
| MP3-Player | 2 | 2013 | 3 | 0.390 |
Why?
|
| Type A Personality | 9 | 1992 | 9 | 0.390 |
Why?
|
| Age Factors | 7 | 2019 | 738 | 0.380 |
Why?
|
| Educational Status | 6 | 2009 | 283 | 0.380 |
Why?
|
| Body Weight | 2 | 2018 | 130 | 0.370 |
Why?
|
| Research Design | 2 | 2013 | 176 | 0.360 |
Why?
|
| Testosterone | 5 | 2015 | 23 | 0.350 |
Why?
|
| Evidence-Based Medicine | 1 | 2011 | 162 | 0.340 |
Why?
|
| Prevalence | 7 | 2016 | 431 | 0.340 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2011 | 103 | 0.340 |
Why?
|
| Religion and Medicine | 3 | 2011 | 25 | 0.330 |
Why?
|
| Mammography | 2 | 2013 | 43 | 0.330 |
Why?
|
| Hospital Mortality | 2 | 2001 | 127 | 0.330 |
Why?
|
| Practice Guidelines as Topic | 1 | 2011 | 251 | 0.320 |
Why?
|
| Attitude to Health | 3 | 2011 | 98 | 0.320 |
Why?
|
| Circadian Rhythm | 2 | 2010 | 235 | 0.320 |
Why?
|
| Religion | 2 | 2009 | 40 | 0.320 |
Why?
|
| Hysterectomy | 2 | 2009 | 23 | 0.310 |
Why?
|
| Patient Participation | 2 | 2008 | 44 | 0.310 |
Why?
|
| Hypertension | 2 | 2014 | 176 | 0.310 |
Why?
|
| Psychophysiology | 1 | 2009 | 6 | 0.310 |
Why?
|
| Life Change Events | 2 | 2004 | 38 | 0.310 |
Why?
|
| Pain | 3 | 2009 | 401 | 0.300 |
Why?
|
| Menstrual Cycle | 2 | 2005 | 17 | 0.300 |
Why?
|
| Diet | 1 | 2010 | 214 | 0.300 |
Why?
|
| Disease Progression | 7 | 2022 | 646 | 0.290 |
Why?
|
| Health Education | 1 | 2008 | 45 | 0.290 |
Why?
|
| Prospective Studies | 8 | 2018 | 1686 | 0.290 |
Why?
|
| Single-Blind Method | 3 | 2013 | 100 | 0.280 |
Why?
|
| Tomography, X-Ray Computed | 9 | 2022 | 631 | 0.270 |
Why?
|
| Prognosis | 8 | 2018 | 695 | 0.270 |
Why?
|
| Clinical Trials as Topic | 3 | 2010 | 196 | 0.260 |
Why?
|
| Personal Autonomy | 2 | 2018 | 9 | 0.260 |
Why?
|
| Overweight | 4 | 2022 | 71 | 0.260 |
Why?
|
| Estradiol | 5 | 2015 | 46 | 0.250 |
Why?
|
| Sex Factors | 8 | 2009 | 453 | 0.250 |
Why?
|
| Smoking | 2 | 2023 | 173 | 0.250 |
Why?
|
| Gonadal Hormones | 1 | 2005 | 2 | 0.250 |
Why?
|
| Severity of Illness Index | 6 | 2010 | 830 | 0.250 |
Why?
|
| Meals | 2 | 2016 | 10 | 0.250 |
Why?
|
| Health Services Misuse | 1 | 2005 | 1 | 0.240 |
Why?
|
| Uterine Diseases | 1 | 2005 | 1 | 0.240 |
Why?
|
| Multilingualism | 1 | 2005 | 11 | 0.240 |
Why?
|
| Vulnerable Populations | 1 | 2005 | 24 | 0.240 |
Why?
|
| Acculturation | 1 | 2005 | 31 | 0.240 |
Why?
|
| Language | 1 | 2005 | 53 | 0.230 |
Why?
|
| Sexual Partners | 1 | 2004 | 17 | 0.230 |
Why?
|
| Affect | 1 | 2005 | 58 | 0.220 |
Why?
|
| Sexual Behavior | 1 | 2004 | 52 | 0.220 |
Why?
|
| Stroke Volume | 2 | 2014 | 32 | 0.220 |
Why?
|
| Patient Acceptance of Health Care | 2 | 2004 | 76 | 0.220 |
Why?
|
| Self Report | 2 | 2016 | 207 | 0.210 |
Why?
|
| Social Class | 2 | 2016 | 60 | 0.210 |
Why?
|
| Administration, Inhalation | 2 | 2013 | 23 | 0.210 |
Why?
|
| Arousal | 3 | 2002 | 50 | 0.210 |
Why?
|
| Sex Hormone-Binding Globulin | 4 | 2011 | 13 | 0.210 |
Why?
|
| Emergency Service, Hospital | 2 | 2018 | 261 | 0.210 |
Why?
|
| Hormone Replacement Therapy | 3 | 2013 | 33 | 0.200 |
Why?
|
| Angiotensin Receptor Antagonists | 2 | 2013 | 6 | 0.200 |
Why?
|
| Sleep | 1 | 2005 | 323 | 0.200 |
Why?
|
| Perimenopause | 3 | 2008 | 10 | 0.200 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 2 | 2013 | 15 | 0.200 |
Why?
|
| Norepinephrine | 1 | 2002 | 30 | 0.190 |
Why?
|
| Caregivers | 1 | 2004 | 188 | 0.190 |
Why?
|
| Epinephrine | 1 | 2002 | 31 | 0.190 |
Why?
|
| Motivation | 2 | 2014 | 89 | 0.190 |
Why?
|
| Weight Loss | 2 | 2022 | 117 | 0.180 |
Why?
|
| Psychophysiologic Disorders | 1 | 2001 | 7 | 0.180 |
Why?
|
| Premenopause | 2 | 2017 | 10 | 0.180 |
Why?
|
| Chi-Square Distribution | 2 | 2011 | 127 | 0.180 |
Why?
|
| Patient Care Team | 2 | 2016 | 113 | 0.180 |
Why?
|
| Psychotherapy, Group | 2 | 2013 | 40 | 0.180 |
Why?
|
| Sick Role | 2 | 2000 | 16 | 0.180 |
Why?
|
| Confidence Intervals | 3 | 2011 | 88 | 0.170 |
Why?
|
| Aged, 80 and over | 5 | 2018 | 4633 | 0.170 |
Why?
|
| Hot Flashes | 3 | 2011 | 9 | 0.170 |
Why?
|
| Health Surveys | 3 | 2009 | 85 | 0.160 |
Why?
|
| Aorta, Thoracic | 1 | 2019 | 7 | 0.160 |
Why?
|
| Cardiovascular System | 1 | 2019 | 12 | 0.160 |
Why?
|
| Psychiatric Status Rating Scales | 4 | 2014 | 291 | 0.160 |
Why?
|
| Predictive Value of Tests | 4 | 2012 | 421 | 0.160 |
Why?
|
| Walking Speed | 1 | 2019 | 40 | 0.160 |
Why?
|
| Biomarkers | 1 | 2002 | 536 | 0.160 |
Why?
|
| Multivariate Analysis | 5 | 2013 | 309 | 0.160 |
Why?
|
| Psychological Tests | 2 | 2009 | 50 | 0.150 |
Why?
|
| Advance Care Planning | 1 | 2018 | 12 | 0.150 |
Why?
|
| Goals | 1 | 2018 | 39 | 0.150 |
Why?
|
| Alcohol Drinking | 2 | 2010 | 75 | 0.140 |
Why?
|
| Estrogen Replacement Therapy | 2 | 2006 | 20 | 0.140 |
Why?
|
| Recurrence | 10 | 2007 | 290 | 0.140 |
Why?
|
| Waist-Height Ratio | 1 | 2016 | 4 | 0.130 |
Why?
|
| Randomized Controlled Trials as Topic | 3 | 2013 | 264 | 0.130 |
Why?
|
| Metabolic Diseases | 1 | 2016 | 7 | 0.130 |
Why?
|
| Food Preferences | 1 | 2016 | 18 | 0.130 |
Why?
|
| Tunica Intima | 3 | 2011 | 9 | 0.130 |
Why?
|
| Illinois | 2 | 2009 | 236 | 0.130 |
Why?
|
| Multiple Chronic Conditions | 1 | 2016 | 9 | 0.130 |
Why?
|
| Ear, External | 1 | 1996 | 2 | 0.130 |
Why?
|
| Ultrasonography | 4 | 2018 | 221 | 0.130 |
Why?
|
| Patient Care Management | 1 | 2016 | 16 | 0.130 |
Why?
|
| Patient Health Questionnaire | 1 | 2016 | 12 | 0.120 |
Why?
|
| Propensity Score | 1 | 2016 | 31 | 0.120 |
Why?
|
| Climacteric | 1 | 2015 | 2 | 0.120 |
Why?
|
| Estrogens, Conjugated (USP) | 2 | 2013 | 4 | 0.120 |
Why?
|
| Medroxyprogesterone Acetate | 2 | 2013 | 4 | 0.120 |
Why?
|
| Community Mental Health Services | 1 | 2015 | 14 | 0.120 |
Why?
|
| Estrogens | 2 | 2013 | 25 | 0.120 |
Why?
|
| Role | 2 | 2012 | 8 | 0.120 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2016 | 141 | 0.120 |
Why?
|
| Antidepressive Agents | 2 | 2007 | 92 | 0.120 |
Why?
|
| New Jersey | 2 | 2005 | 3 | 0.120 |
Why?
|
| Parents | 1 | 2016 | 108 | 0.120 |
Why?
|
| Research | 1 | 2015 | 37 | 0.120 |
Why?
|
| Pilot Projects | 4 | 2014 | 394 | 0.120 |
Why?
|
| Smartphone | 1 | 2015 | 13 | 0.120 |
Why?
|
| Health Policy | 1 | 2015 | 41 | 0.110 |
Why?
|
| Mobile Applications | 1 | 2015 | 25 | 0.110 |
Why?
|
| Cost of Illness | 1 | 2015 | 47 | 0.110 |
Why?
|
| Reproducibility of Results | 1 | 2016 | 619 | 0.110 |
Why?
|
| Lipoproteins, HDL | 2 | 2014 | 19 | 0.110 |
Why?
|
| Quality Improvement | 1 | 2015 | 130 | 0.110 |
Why?
|
| Carotid Arteries | 2 | 2011 | 13 | 0.110 |
Why?
|
| Weight Gain | 2 | 2007 | 61 | 0.110 |
Why?
|
| Tunica Media | 2 | 2011 | 5 | 0.110 |
Why?
|
| Body Image | 1 | 2014 | 20 | 0.110 |
Why?
|
| Vaginal Smears | 1 | 2013 | 12 | 0.110 |
Why?
|
| Papanicolaou Test | 1 | 2013 | 10 | 0.110 |
Why?
|
| Survival Rate | 2 | 2012 | 294 | 0.110 |
Why?
|
| New York | 1 | 2013 | 11 | 0.100 |
Why?
|
| Peer Group | 1 | 2013 | 32 | 0.100 |
Why?
|
| Community Health Services | 1 | 2013 | 33 | 0.100 |
Why?
|
| Social Environment | 2 | 1992 | 76 | 0.100 |
Why?
|
| Cross-Cultural Comparison | 2 | 2010 | 30 | 0.100 |
Why?
|
| Organ Size | 2 | 2009 | 93 | 0.100 |
Why?
|
| Health Status Indicators | 1 | 2013 | 67 | 0.100 |
Why?
|
| Interviews as Topic | 3 | 2018 | 129 | 0.100 |
Why?
|
| Personality Assessment | 1 | 1992 | 33 | 0.100 |
Why?
|
| Early Detection of Cancer | 1 | 2013 | 102 | 0.100 |
Why?
|
| Time Factors | 5 | 2014 | 1376 | 0.100 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2011 | 24 | 0.090 |
Why?
|
| Retrospective Studies | 7 | 2017 | 3342 | 0.090 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2011 | 4 | 0.090 |
Why?
|
| Gonadal Steroid Hormones | 1 | 2011 | 10 | 0.090 |
Why?
|
| School Health Services | 1 | 2011 | 18 | 0.090 |
Why?
|
| Risk | 5 | 2013 | 202 | 0.090 |
Why?
|
| Adaptation, Psychological | 3 | 2009 | 167 | 0.090 |
Why?
|
| Students | 1 | 2011 | 47 | 0.090 |
Why?
|
| Coronary Angiography | 3 | 2017 | 53 | 0.090 |
Why?
|
| Waist-Hip Ratio | 1 | 2010 | 12 | 0.090 |
Why?
|
| Nutrition Policy | 1 | 2010 | 8 | 0.080 |
Why?
|
| Sertraline | 2 | 2007 | 24 | 0.080 |
Why?
|
| France | 1 | 2010 | 11 | 0.080 |
Why?
|
| Saliva | 1 | 2010 | 50 | 0.080 |
Why?
|
| Fruit | 1 | 2010 | 27 | 0.080 |
Why?
|
| Vegetables | 1 | 2010 | 26 | 0.080 |
Why?
|
| Linear Models | 1 | 2011 | 241 | 0.080 |
Why?
|
| Carcinoma, Ductal, Breast | 1 | 2010 | 30 | 0.080 |
Why?
|
| Dietary Fats | 1 | 2010 | 39 | 0.080 |
Why?
|
| Double-Blind Method | 2 | 2008 | 370 | 0.080 |
Why?
|
| Morbidity | 3 | 2008 | 50 | 0.080 |
Why?
|
| Energy Intake | 1 | 2010 | 80 | 0.080 |
Why?
|
| Communication | 2 | 2007 | 104 | 0.080 |
Why?
|
| Vitamin D | 1 | 2010 | 35 | 0.080 |
Why?
|
| California | 2 | 2005 | 31 | 0.080 |
Why?
|
| Leiomyoma | 1 | 2009 | 5 | 0.080 |
Why?
|
| Uterus | 1 | 2009 | 17 | 0.080 |
Why?
|
| Cognition | 2 | 2010 | 1307 | 0.080 |
Why?
|
| Uterine Neoplasms | 1 | 2009 | 12 | 0.080 |
Why?
|
| Down-Regulation | 1 | 2009 | 104 | 0.080 |
Why?
|
| Physical Fitness | 1 | 2009 | 42 | 0.080 |
Why?
|
| Aging | 4 | 2009 | 1503 | 0.080 |
Why?
|
| Pain Measurement | 2 | 2009 | 477 | 0.080 |
Why?
|
| Models, Statistical | 1 | 2009 | 124 | 0.080 |
Why?
|
| Body Composition | 1 | 2009 | 63 | 0.080 |
Why?
|
| Insulin Resistance | 2 | 2009 | 45 | 0.070 |
Why?
|
| Meditation | 1 | 2009 | 23 | 0.070 |
Why?
|
| Behavioral Medicine | 1 | 2008 | 6 | 0.070 |
Why?
|
| Demography | 2 | 2006 | 70 | 0.070 |
Why?
|
| Carotid Artery, Common | 1 | 2008 | 3 | 0.070 |
Why?
|
| Death, Sudden | 1 | 1988 | 7 | 0.070 |
Why?
|
| Diagnosis-Related Groups | 1 | 1988 | 8 | 0.070 |
Why?
|
| Regression Analysis | 2 | 2005 | 246 | 0.070 |
Why?
|
| Behavior | 2 | 1985 | 25 | 0.070 |
Why?
|
| Animals | 1 | 2015 | 3504 | 0.070 |
Why?
|
| Music | 1 | 2008 | 22 | 0.070 |
Why?
|
| Activities of Daily Living | 2 | 2009 | 584 | 0.070 |
Why?
|
| Vitamins | 1 | 2007 | 19 | 0.070 |
Why?
|
| Cholecalciferol | 1 | 2007 | 7 | 0.070 |
Why?
|
| Anti-Obesity Agents | 1 | 2007 | 4 | 0.070 |
Why?
|
| Calcium, Dietary | 1 | 2007 | 13 | 0.070 |
Why?
|
| Bone Density Conservation Agents | 1 | 2007 | 14 | 0.070 |
Why?
|
| Survival Analysis | 3 | 2004 | 234 | 0.070 |
Why?
|
| Follicle Stimulating Hormone | 3 | 2015 | 20 | 0.070 |
Why?
|
| Proportional Hazards Models | 4 | 2004 | 313 | 0.070 |
Why?
|
| Self Concept | 3 | 2002 | 38 | 0.070 |
Why?
|
| Incidence | 3 | 2017 | 720 | 0.070 |
Why?
|
| Referral and Consultation | 1 | 2007 | 87 | 0.070 |
Why?
|
| Mortality | 2 | 2007 | 85 | 0.060 |
Why?
|
| Sweating | 1 | 2006 | 2 | 0.060 |
Why?
|
| Bariatric Surgery | 1 | 2007 | 52 | 0.060 |
Why?
|
| Sleep Disorders, Intrinsic | 1 | 2005 | 4 | 0.060 |
Why?
|
| Focus Groups | 1 | 2006 | 83 | 0.060 |
Why?
|
| Communication Barriers | 1 | 2005 | 2 | 0.060 |
Why?
|
| Attitude | 2 | 2002 | 33 | 0.060 |
Why?
|
| Social Behavior | 1 | 2006 | 65 | 0.060 |
Why?
|
| Masturbation | 1 | 2004 | 1 | 0.060 |
Why?
|
| Pennsylvania | 1 | 2004 | 5 | 0.060 |
Why?
|
| Reinforcement, Social | 1 | 2004 | 1 | 0.060 |
Why?
|
| Utilization Review | 1 | 2004 | 1 | 0.060 |
Why?
|
| Breast Self-Examination | 1 | 2004 | 3 | 0.060 |
Why?
|
| Statistics as Topic | 1 | 2004 | 103 | 0.060 |
Why?
|
| Health Promotion | 1 | 2006 | 138 | 0.060 |
Why?
|
| Hand Strength | 1 | 2004 | 56 | 0.050 |
Why?
|
| Interpersonal Relations | 1 | 2004 | 101 | 0.050 |
Why?
|
| Substance-Related Disorders | 1 | 2004 | 93 | 0.050 |
Why?
|
| Young Adult | 1 | 2009 | 1929 | 0.050 |
Why?
|
| Muscle, Skeletal | 1 | 2006 | 378 | 0.050 |
Why?
|
| Men | 1 | 2022 | 4 | 0.050 |
Why?
|
| Occupations | 1 | 2022 | 18 | 0.050 |
Why?
|
| Death | 1 | 2003 | 43 | 0.050 |
Why?
|
| Divorce | 1 | 2002 | 2 | 0.050 |
Why?
|
| Sympathetic Nervous System | 1 | 2002 | 12 | 0.050 |
Why?
|
| Psychology | 1 | 2002 | 21 | 0.050 |
Why?
|
| Reference Values | 1 | 2002 | 175 | 0.050 |
Why?
|
| Sleep Wake Disorders | 1 | 2003 | 115 | 0.050 |
Why?
|
| Electrocardiography | 2 | 2016 | 84 | 0.040 |
Why?
|
| Random Allocation | 4 | 1988 | 123 | 0.040 |
Why?
|
| Analysis of Variance | 2 | 1993 | 248 | 0.040 |
Why?
|
| Brazil | 1 | 2000 | 42 | 0.040 |
Why?
|
| Drug Therapy, Combination | 2 | 2013 | 158 | 0.040 |
Why?
|
| Neoplasms | 1 | 2003 | 220 | 0.040 |
Why?
|
| Cause of Death | 1 | 2000 | 56 | 0.040 |
Why?
|
| Risk Assessment | 2 | 2017 | 553 | 0.040 |
Why?
|
| Inpatients | 1 | 2001 | 121 | 0.040 |
Why?
|
| Cognition Disorders | 1 | 2006 | 961 | 0.040 |
Why?
|
| Emotions | 1 | 1999 | 72 | 0.040 |
Why?
|
| Mental Disorders | 1 | 2001 | 141 | 0.040 |
Why?
|
| Pulse Wave Analysis | 1 | 2018 | 3 | 0.040 |
Why?
|
| Vascular Stiffness | 1 | 2018 | 4 | 0.040 |
Why?
|
| Combined Modality Therapy | 3 | 2007 | 286 | 0.040 |
Why?
|
| Age Distribution | 2 | 2009 | 83 | 0.030 |
Why?
|
| Pericardium | 1 | 2017 | 16 | 0.030 |
Why?
|
| Decision Making | 1 | 2018 | 214 | 0.030 |
Why?
|
| Personality Inventory | 2 | 2007 | 73 | 0.030 |
Why?
|
| Death, Sudden, Cardiac | 1 | 1995 | 8 | 0.030 |
Why?
|
| Disease-Free Survival | 1 | 1996 | 149 | 0.030 |
Why?
|
| Policy Making | 1 | 2015 | 12 | 0.030 |
Why?
|
| Epidemiologic Research Design | 1 | 2015 | 15 | 0.030 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2015 | 23 | 0.030 |
Why?
|
| Health Services Needs and Demand | 1 | 2015 | 43 | 0.030 |
Why?
|
| Heart Arrest | 1 | 1995 | 38 | 0.030 |
Why?
|
| Waist Circumference | 1 | 2014 | 31 | 0.030 |
Why?
|
| Hypertriglyceridemia | 1 | 2014 | 18 | 0.030 |
Why?
|
| Neuropsychological Tests | 2 | 2010 | 1164 | 0.030 |
Why?
|
| Biomedical Research | 1 | 2015 | 55 | 0.030 |
Why?
|
| Health Services Accessibility | 1 | 2015 | 110 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 2014 | 200 | 0.030 |
Why?
|
| Population Surveillance | 1 | 2014 | 108 | 0.030 |
Why?
|
| Diabetic Angiopathies | 1 | 2013 | 2 | 0.030 |
Why?
|
| Income | 2 | 2004 | 74 | 0.030 |
Why?
|
| Endometrial Neoplasms | 1 | 2013 | 25 | 0.030 |
Why?
|
| Radiography | 1 | 2015 | 611 | 0.030 |
Why?
|
| Hip Fractures | 1 | 2013 | 26 | 0.030 |
Why?
|
| Exercise Test | 1 | 2013 | 64 | 0.030 |
Why?
|
| Psychometrics | 2 | 2003 | 203 | 0.030 |
Why?
|
| Pulmonary Embolism | 1 | 2013 | 54 | 0.020 |
Why?
|
| Cholesterol, HDL | 2 | 2010 | 22 | 0.020 |
Why?
|
| Colorectal Neoplasms | 1 | 2013 | 111 | 0.020 |
Why?
|
| Vasomotor System | 1 | 2011 | 2 | 0.020 |
Why?
|
| Religion and Psychology | 1 | 2011 | 24 | 0.020 |
Why?
|
| Multicenter Studies as Topic | 1 | 2010 | 41 | 0.020 |
Why?
|
| Stroke | 1 | 2013 | 262 | 0.020 |
Why?
|
| Calcifediol | 1 | 2010 | 1 | 0.020 |
Why?
|
| 25-Hydroxyvitamin D 2 | 1 | 2010 | 1 | 0.020 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2010 | 35 | 0.020 |
Why?
|
| Particle Size | 1 | 2010 | 48 | 0.020 |
Why?
|
| Biological Availability | 1 | 2009 | 13 | 0.020 |
Why?
|
| Ultrasonography, Doppler, Duplex | 1 | 2009 | 14 | 0.020 |
Why?
|
| Anthropometry | 1 | 2009 | 30 | 0.020 |
Why?
|
| Uterine Prolapse | 1 | 2009 | 2 | 0.020 |
Why?
|
| Calcium | 1 | 2012 | 342 | 0.020 |
Why?
|
| Videotape Recording | 2 | 1985 | 18 | 0.020 |
Why?
|
| Connective Tissue | 1 | 2008 | 24 | 0.020 |
Why?
|
| Cholesterol | 2 | 1985 | 62 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2007 | 314 | 0.020 |
Why?
|
| Factor Analysis, Statistical | 1 | 2006 | 50 | 0.020 |
Why?
|
| Anger | 1 | 2006 | 33 | 0.020 |
Why?
|
| Anxiety | 1 | 2006 | 143 | 0.010 |
Why?
|
| Skin Pigmentation | 1 | 1985 | 5 | 0.010 |
Why?
|
| Interview, Psychological | 1 | 1985 | 41 | 0.010 |
Why?
|
| Residence Characteristics | 1 | 2006 | 206 | 0.010 |
Why?
|
| Body Constitution | 1 | 2004 | 3 | 0.010 |
Why?
|
| Pregnanediol | 1 | 2004 | 5 | 0.010 |
Why?
|
| Estrone | 1 | 2004 | 7 | 0.010 |
Why?
|
| Corpus Luteum | 1 | 2004 | 4 | 0.010 |
Why?
|
| Luteinizing Hormone | 1 | 2004 | 10 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2005 | 450 | 0.010 |
Why?
|
| Blood Glucose | 1 | 2004 | 99 | 0.010 |
Why?
|
| Acute Disease | 1 | 2003 | 165 | 0.010 |
Why?
|
| Memory | 1 | 2003 | 286 | 0.010 |
Why?
|
| Telephone | 1 | 2001 | 26 | 0.010 |
Why?
|
| Sex Characteristics | 1 | 1999 | 115 | 0.010 |
Why?
|
| Mental Health | 1 | 1999 | 107 | 0.010 |
Why?
|
| Myocardial Ischemia | 1 | 1995 | 29 | 0.010 |
Why?
|
| Arrhythmias, Cardiac | 1 | 1995 | 61 | 0.010 |
Why?
|
| Personality Tests | 1 | 1991 | 5 | 0.010 |
Why?
|
| Insurance, Health | 1 | 1989 | 19 | 0.000 |
Why?
|
| Employment | 1 | 1989 | 39 | 0.000 |
Why?
|
| Time Perception | 1 | 1985 | 5 | 0.000 |
Why?
|
| Military Medicine | 1 | 1985 | 8 | 0.000 |
Why?
|
| Marriage | 1 | 1985 | 6 | 0.000 |
Why?
|
| Leadership | 1 | 1985 | 92 | 0.000 |
Why?
|
| Group Processes | 1 | 1984 | 14 | 0.000 |
Why?
|